Bliss GVS Pharma LtdPharmaceuticalsINE416D01022Consolidated₹690.40+32.85 (+5.00%)Jun-26
Valuation
Market Cap₹7.37K Cr
TTM PE53.93x
Forward PE50.58x
PEG10.16
Book Value₹112.48
P/B6.18x
TTM EPS₹12.88
Fwd EPS₹13.73
TTM Revenue₹1.01K Cr
TTM PAT₹141.74 Cr
TTM EBITDA₹187.40 Cr
TTM EBIT₹152.18 Cr
Last Qtr PAT₹51.37 Cr
Last Qtr EBITDA₹76.41 Cr
Last Qtr EBIT₹66.47 Cr
Profitability
ROE11.88%
ROCE17.21%
TTM NPM14.10%
TTM EBITDA %18.64%
Curr OPM17.40%
Last OPM13.80%
Curr NPM—
Last NPM—
Curr EPS₹4.73
Last EPS₹3.37
Balance sheet
Equity₹10.58 Cr
Reserve₹1.18K Cr
Total Debt₹21.75 Cr
D/E0.02x
Interest %1.13%
Curr Interest₹0.58 Cr
Price / range
Close₹694.60
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+5.00%
1W+0.59%
1M+18.57%
3M+45.87%
6M+227.36%
1Y+358.78%
2Y+435.54%
3Y+656.32%
5Y+521.29%
Diwali+328.77%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits